Trials / Completed
CompletedNCT01895933
Efficacy and Safety of the Investigational Device, SurgiShield Anti-Adhesion Barrier Gel
The Aim of This Study is to Evaluate the Efficacy and Safety of the Investigational Device, SurgiShield Anti-Adhesion Barrier Gel Made by D Med
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- D.med · Industry
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial is intended to evaluate the impact, efficacy, and safety of Chitosan formulated adhesion inhibitor, SurgiShield when used in the process of wound healing after endoscopic sinus surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 5ml surgishield | in the case of active, apply solution type adhesion barrier to merocel and pack 5ml of adhesion inhibitor Surgi Shield on the surgical site merocel in the inflated state maintained for 36\~48 hours, remove packing then solution type adhesion inhibitor is to be injected in to the surgical site |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2013-07-11
- Last updated
- 2023-12-08
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01895933. Inclusion in this directory is not an endorsement.